Vanthys Pharmaceutical Development Private Limited - Company Profile

It is a pharma private limited company based in Noida, Uttar Pradesh, India, established in 2009.

2009 Noida, Uttar Pradesh, India Dissolved (Liquidated)

Last Updated: July 25, 2025

About Vanthys Pharmaceutical Development Private Limited

Vanthys Pharmaceutical Development Private Limited, a dissolved (liquidated) private limited company, was established on 11 May 2009 in Noida, Uttar Pradesh, India. Engaging in pharma contract r&d within the pharma sector, it holds CIN: U73100UP2009PTC037333. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹22.50 Cr and a paid-up capital of ₹22.50 Cr.

It upholds a compliant status. Its leadership includes Benny Thomas (Director), Saravanakumar Dhakshinamoorthy (Additional Director), Shwetank Tiwari (Company Secretary). Past directors included Prakash Chandra Bisht, Hari Shanker Bhartia, Shyam Nath Singh. Its latest AGM occurred on 20 September 2018, with the balance sheet filed on 31 March 2018. It is based at 1A, Sector 16A Institutional Area, Noida, Uttar Pradesh, 201301.

Company Details

CIN/LLPIN
U73100UP2009PTC037333
Registration Number
037333
Incorporation Date
11 May 2009
Authorized Capital
₹22.50 Cr
Paid-Up Capital
₹22.50 Cr
ROC Code
Roc Kanpur
Listing Status
Unlisted
Company Status
Dissolved (Liquidated)

Key Metrics

Authorised Capital ₹ 22.50 Cr as on 25-07-2025
Paid Up Capital ₹ 22.50 Cr as on 25-07-2025
Company Age 16 Year, 9 Months
Last Filing with ROC 31 Mar 2018
Revenue Growth **** 0.03% (FY 2018)
Profit Growth **** 8.39% (FY 2018)
Ebitda **** 5.94% (FY 2018)
Net Worth 6.02% (FY 2018)
Total Assets **** 4.27% (FY 2018)

Comprehensive Company Insights

Explore comprehensive insights into Vanthys Pharmaceutical Development Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Vanthys Pharmaceutical Development Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Benny Thomas	Director	28 Mar 2018	Current
Saravanakumar Dhakshinamoorthy	Additional Director	15 May 2019	Current
Shwetank Tiwari	Company Secretary	16 Jan 2018	Current
Shyamsundar Bang	Director	28 Mar 2018	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	18 Jan 2018	Past
Pramod Abcsdd	Director	06 Mar 2013	Past
Pramod Abcsdd	Director	28 Mar 2018	Past
Pramod Abcsdd	Director	28 Mar 2018	Past
Pramod Abcsdd	Company Secretary	03 Apr 2013	Past
Pramod Abcsdd	Key Managerial Personnel	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vanthys Pharmaceutical Development.

Vanthys Pharmaceutical Development Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 0.03% increase. The company also saw a slight improvement in profitability, with a 8.39% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

0.03%

*******

Revenue from Operations

*******

Total Assets

*******

4.27%

*******

Profit or Loss

*******

8.39%

*******

Net Worth

*******

6.02%

*******

EBITDA

*******

5.94%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vanthys Pharmaceutical Development?

In 2018, Vanthys Pharmaceutical Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Vanthys Pharmaceutical Development?

Unlock and access historical data on people associated with Vanthys Pharmaceutical Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vanthys Pharmaceutical Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanthys Pharmaceutical Development's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vanthys Pharmaceutical Development

Recent Activity within the Organization

Director Appointment

The activity Saravanakumar Dhakshinamoorthy was appointed as a Additional Director was appointed as a Additional Director on 15 May 2019 & has been associated with this company since 6 years 9 months . was completed.
15 May 2019
Annual General Meeting

Progress on Vanthys Pharmaceutical Development Private Limited last Annual general meeting of members was held on 20 Sep 2018 as per latest MCA records. was documented.
20 Sep 2018
Balance Sheet

The activity Vanthys Pharmaceutical Development Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kanpur. was completed.
31 Mar 2018
Director Appointment

Benny Thomas was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
28 Mar 2018
Director Appointment

Shyamsundar Bang was appointed as a Director was appointed as a Director on 28 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
28 Mar 2018
Director Appointment

Progress on Shwetank Tiwari was appointed as a Company Secretary was appointed as a Company Secretary on 16 Jan 2018 & has been associated with this company since 8 years 1 month . was documented.
16 Jan 2018

Explore recent activity and updates - View Recent Activity